Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Total Non-Current Liabilities (2017 - 2025)

Selectis Health's Total Non-Current Liabilities history spans 11 years, with the latest figure at $38.8 million for Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities changed 0.39% year-over-year to $38.8 million; the TTM value through Sep 2025 reached $38.8 million, changed 0.39%, while the annual FY2024 figure was $38.8 million, 10.53% down from the prior year.
  • Total Non-Current Liabilities for Q3 2025 was $38.8 million at Selectis Health, down from $39.9 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $43.8 million in Q2 2023 and bottomed at $38.7 million in Q3 2024.
  • The 5-year median for Total Non-Current Liabilities is $42.1 million (2022), against an average of $41.6 million.
  • The largest annual shift saw Total Non-Current Liabilities increased 5.56% in 2021 before it decreased 10.53% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $43.6 million in 2021, then fell by 5.38% to $41.2 million in 2022, then increased by 5.03% to $43.3 million in 2023, then fell by 10.53% to $38.8 million in 2024, then rose by 0.13% to $38.8 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Total Non-Current Liabilities are $38.8 million (Q3 2025), $39.9 million (Q2 2025), and $40.5 million (Q1 2025).